Temporal trends in lipoprotein(a) testing among United States veterans from 2014 to 2023

Temporal trends in lipoprotein(a) testing among United States veterans from 2014 to 2023

Objective: Lipoprotein (a) [Lp(a)] is a causal, genetically-inherited risk amplifier for atherosclerotic cardiovascular disease (ASCVD). Practice guidelines increasingly recommend broad Lp(a) screening among various populations to optimize preventive care. Corresponding changes in testing rates and...

Descrición completa

Detalles Bibliográficos
Main Authors: Sofia E. Gomez, Adam Furst, Tania Chen, Natasha Din, David J. Maron, Paul Heidenreich, Neil Kalwani, Shriram Nallamshetty, Jonathan H Ward, Anthony Lozama, Alexander Sandhu, Fatima Rodriguez
Formato: Artigo
Idioma:English
Publicado: Elsevier 2024-12-01
Series:American Journal of Preventive Cardiology
Subjects:
Lipoprotein(a)
Testing
Prevention
Atherosclerotic cardiovascular disease
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S266666772400240X

Internet

http://www.sciencedirect.com/science/article/pii/S266666772400240X

Títulos similares